Limitations, agreements, and source contact

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain · Source last updated 2014-03-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

ldillaha@insysrx.com

organization

Insys Therapeutics, Inc.

phone

602 910-2617

title

Larry Dillaha, M.D., Chief Medical Officer

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice